Chol-Less Max
95/100
This product looks safe
- Niacin: 1080mg is 30.9× the Tolerable Upper Intake Level (35mg)
- 75% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 1080mg is 30.9× the Tolerable Upper Intake Level (35mg)
Label Data
3 Capsule(s)
Serving Size
45
Servings
Other Combinations
Product Type
75%
Evidence Coverage
Supplement Facts — Evidence Check
1080 mg
(5625% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 30.9× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
1 mg
(833% DV)
📊 28.6× RDA — above typical dose
📚 197 studies (Tier A: 1, B: 55)
1350 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
270 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
900 mg
📊 Market median: 500.0mg (234 products)
📚 95 studies (Tier A: 0, B: 35)
Artichoke (leaf) extract
45 mg
Policosanol
36 mg
585 mg
📊 Market median: 500.0mg (497 products)
📚 132 studies (Tier A: 0, B: 40)
Other Ingredients
Gelatin
Magnesium Stearate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, 3-6 capsules per day or as directed by your physician.
⚠️ Warnings & Precautions
Warning: If you are under medical supervision, seek the advice of your physician or healthcare professional prior to use of this product. Individuals with autoimmune conditions, depressive disorders or pregnant/lactating women should consult their physician prior to use.
Keep out of reach of children.
Transient ushing of the skin can follow ingestion of niacin, especially if taken with little or no food.
Additional Information
*Synergistic Cholesterol Lowering Formula
Store in a cool, dry place protected from light.
Product Details
UPC / SKU
8 37654 69357 5
DSLD Entry Date
2013-03-25
Product Type
Other Combinations
Form
Capsule
Brand
HoltraCeuticals
DSLD ID
19374
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100